Baylor, GE Medical Launch ‘The Health Channel’

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

HOUSTON-GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

HOUSTON—GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

The new service, called The Health Channel, is directed by Baylor College of Medicine and Texas Children’s Hospital, and is available through GE Medical Systems’ TiP-TV satellite broadcast network. Currently, 1,600 health care facilities in the US, Canada, and Europe provide TiP-TV programming to their staff.

Programs are developed and accredited by Baylor in cooperation with a consortium of leading academic medical institutions, including The Cleveland Clinic Foundation, Duke University Medical Center, the Mayo Clinic, M.D. Anderson Cancer Center, and others.

Programs repeat frequently to accommodate various day and night staff schedules. The channel runs 24 hours a day, 7 days a week, with new programming offered every week. A bi-monthly broadcast guide lists dates and times.

The monthly subscription rate for The Health Channel varies depending on hospital bed size and can range from $750 to $3,000. Hospitals can subscribe by calling toll free 1-877-GE TiPTV (1-877-438-4788). More information on the new service is available at the Channel’s website, www.healthchannelweb.com.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content